Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03979872 · ClinicalTrials.gov registry record · NA
Risk Information and Skin-cancer Education for Undergraduate Prevention
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 92
- Enrollment target
NCT03979872: Completed NA study, sponsored by University of Utah.
NCT03979872 is a NA study that has completed, run by University of Utah. The registered enrollment target is 92 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03979872, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
Study Summary
The purpose of this study will be to provide undergraduate students information about skin cancer risk and prevention. The study will last between 2-3 months. Everyone in the study will be asked to answer questionnaires and receive education about skin cancer risk factors and prevention. We will follow-up with participants by phone, text messages or e-mail in between study visits Participants will be randomly assigned to one of four groups, the group will be in is decided by chance. Participant will either be assigned to: * A group that gets advice about what causes skin cancer and how to prevent it * A group that gets this advice and provides a saliva sample to receive personalized skin cancer risk genetic testing results * A group that gets this advice and receives a personalized photo that shows existing skin damage * A group that gets this advice, receives genetic testing results, and receives a personalized photo.
Primary Outcome
Mean and standard deviation for each sun protection behavior at Visit 1 (baseline), Visit 2 (4 weeks), Visit 3 (8 weeks). "These next questions ask about what you have done in the past four weeks if you were outdoors in the sun for 15 minutes or more. How often did you... " Minimum value =1; Maximum value= 5; Higher scores indicate that participants were more likely to engage in sun protection habits.
Interventions
- DIAGNOSTIC_TEST MC1R Genetic Testing
- OTHER Skin Cancer Education
- DEVICE UV Photo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2019-09-09 |
| Est. Completion | 2020-08-01 |
| Phase | NA |
What the finished NCT03979872 record still lists
NCT03979872 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which MC1R Genetic Testing is the first listed.
NCT03979872 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03979872 about?
NCT03979872 is a clinical study titled "Risk Information and Skin-cancer Education for Undergraduate Prevention". The purpose of this study will be to provide undergraduate students information about skin cancer risk and prevention. The study will last between 2-3 months. Everyone in the study will be asked to answer questionnaires and receive education about skin cancer risk factors and prevention. We will fol...
What is the current status of trial NCT03979872?
This trial is currently completed. It is a NA study. The enrollment target is 92 participants. The study started on 2019-09-09. Estimated completion is 2020-08-01.
What interventions are being tested in trial NCT03979872?
The interventions under investigation include: MC1R Genetic Testing (DIAGNOSTIC_TEST), Skin Cancer Education (OTHER), UV Photo (DEVICE).
Who is sponsoring clinical trial NCT03979872?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03979872's enrollment target sits among peer trials
92 937th of 2000 higher than 1,062 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI